object
studi
evalu
efficaci
vaccin
prevent
giardia
duodenali
infect
calv
six
old
calv
vaccin
subcutan
sonic
g
duodenali
trophozoit
vaccin
six
old
control
calv
receiv
subcutan
inject
steril
phosphatebufferedsalin
mix
adjuv
inject
repeat
day
eleven
day
second
inject
calv
challeng
oral
purifi
g
duodenali
cyst
natur
infect
calf
throughout
studi
fecal
sampl
collect
regular
interv
examin
presenc
g
duodenali
cyst
blood
sampl
collect
weekli
g
duodenali
challeng
biweekli
follow
challeng
calv
euthan
day
challeng
g
duodenali
trophozoit
within
small
intestin
enumer
serum
antibodi
titer
significantli
higher
vaccin
compar
nonvaccin
calv
vaccin
calv
tend
excret
g
duodenali
cyst
fece
nonvaccin
calv
number
trophozoit
small
intestin
differ
vaccin
nonvaccin
calv
chang
consist
moder
enter
found
intestin
one
vaccin
one
nonvaccin
calf
despit
serolog
immun
respons
follow
vaccin
vaccin
efficaci
prevent
giardiasi
reduc
cyst
shed
calv
giardia
duodenali
syn
g
lamblia
infect
highli
preval
domest
rumin
throughout
world
review
ohandley
olson
typic
infect
occur
rumin
around
one
month
age
chronic
reoccur
cyst
excret
continu
month
initi
infect
wwwelseviercomlocatevetpar
veterinari
parasitolog
host
clinic
sign
associ
g
duodenali
infect
rumin
vari
subclin
infect
often
report
howev
g
duodenali
infect
also
associ
occurr
diarrhea
ill
thrift
calv
ohandley
et
al
geurden
et
al
importantli
previou
research
shown
g
duodenali
infect
result
signific
product
loss
lamb
thu
rais
concern
giardiasi
may
product
limit
diseas
livestock
olson
et
al
ohandley
et
al
aloisio
et
al
addit
although
rumin
commonli
infect
livestock
specif
g
duodenali
genet
assemblag
e
also
infect
g
duodenali
zoonot
genet
assemblag
thu
domest
livestock
potenti
serv
reservoir
human
giardiasi
ohandley
et
al
trout
et
al
uehling
et
al
due
high
preval
potenti
product
impact
zoonot
potenti
g
duodenali
infect
domest
rumin
recent
research
examin
potenti
control
g
duodenali
infect
rumin
chemotherapi
paromomycin
benzimidazol
drug
fenbendazol
show
efficaci
giardiasi
dairi
calv
xiao
et
al
ohandley
et
al
geurden
et
al
howev
due
high
level
g
duodenali
cyst
environ
calv
readili
reinfect
immedi
follow
treatment
ohandley
et
al
continu
administr
drug
fenbendazol
paromomycin
may
allow
longterm
control
giardiasi
rumin
howev
type
treatment
regimen
like
use
econom
feasibl
livestock
produc
vaccin
prevent
control
g
duodenali
domest
rumin
could
practic
costeffect
approach
current
sonic
whole
g
duodenali
vaccin
made
trophozoit
isol
sheep
avail
dog
cat
north
america
olson
et
al
clinic
trial
demonstr
subcutan
administr
vaccin
young
grow
dog
cat
result
reduct
g
duodenali
cyst
fece
elimin
reduct
g
duodenali
trophozoit
intestin
prevent
clinic
diseas
significantli
higher
weight
gain
compar
nonvaccin
anim
olson
et
al
provid
vaccin
similar
efficaci
domest
rumin
could
reduc
elimin
role
domest
rumin
reservoir
g
duodenali
infect
human
may
provid
econom
benefit
livestock
produc
prevent
product
loss
associ
giardiasi
therefor
studi
evalu
efficaci
g
duodenali
vaccin
prevent
giardiasi
calv
twelv
holsteinfriesian
bull
calv
day
old
purchas
eight
local
dairi
farmer
calv
obtain
transport
atlant
veterinari
colleg
avc
day
studi
follow
satisfactori
physic
examin
calv
evalu
failur
passiv
transfer
fpt
immun
determin
serum
total
protein
concentr
includ
studi
serum
protein
concentr
gdl
calloway
et
al
bovin
viru
diarrhea
virusneg
calv
determin
buffi
coat
viru
isol
includ
studi
upon
arriv
avc
calv
hous
individu
isol
unit
veterinari
hospit
pen
consist
concret
floor
solid
wall
prevent
contact
anim
manur
wet
bed
remov
daili
replac
fresh
bed
wood
shave
calv
fed
commerci
milk
replac
twice
daili
feed
concentr
accord
manufactur
instruct
calv
receiv
approxim
kg
loos
hay
everi
day
ad
libitum
access
fresh
water
filter
floccul
chlorin
municip
water
elimin
exist
giardia
duodenali
infect
prior
vaccin
ensur
calv
remain
free
g
duodenali
vaccin
day
calv
treat
mgkg
fenbendazol
per
os
safeguard
suspens
cdmv
st
hyacinth
canada
daili
start
day
day
vaccin
day
medic
attent
requir
studi
calv
respiratori
tract
problem
diarrhea
respiratori
problem
treat
florfenicol
case
high
fever
ketoprofen
nonsteroid
antiinflammatori
drug
support
care
given
diarrheic
calv
need
form
oral
electrolyt
research
project
carri
guidelin
univers
princ
edward
island
anim
care
committe
base
approv
anim
research
guidelin
canadian
council
anim
care
ccac
three
day
vaccin
one
diarrheic
calf
die
result
calf
exclud
studi
reduc
number
vaccin
calv
five
calv
confirm
neg
giardia
duodenali
absenc
g
duodenali
cyst
fecal
sampl
taken
consecut
day
day
randomli
alloc
two
group
six
move
avc
research
barn
group
hous
separ
ident
room
prior
move
calv
thoroughli
wash
water
commerci
avail
liquid
soap
prevent
mechan
introduct
g
duodenali
cyst
room
two
room
sanit
quaternari
ammonium
disinfect
quatricid
pharmac
research
laboratori
inc
naugatuck
usa
allow
dri
complet
prior
start
studi
calf
hous
individu
pen
allow
contact
neighbor
anim
calf
assign
water
feed
bucket
clean
disinfect
regularli
feed
husbandri
protocol
remain
unchang
calv
allow
acclimat
new
hous
day
day
strict
isol
procedur
follow
make
certain
g
duodenali
cyst
introduc
calv
environ
includ
use
clean
coveral
sanit
footwear
glove
chang
anim
follow
acclim
period
one
group
calv
inject
sonic
whole
g
duodenali
trophozoit
vaccin
giardiavax
tm
wyeth
anim
health
guelph
canada
day
one
dose
ml
accord
manufactur
instruct
use
dog
subcutan
inject
neck
use
needl
calv
group
receiv
subcutan
inject
ml
steril
phosphatebufferedsalin
pb
mix
adjuv
adjupho
aluminumphosph
accur
chemic
scientif
corp
westburi
usa
alloc
vaccin
salin
inject
two
group
made
randomli
blind
research
caregiv
twentyeight
day
initi
inject
day
vaccin
salin
inject
repeat
eleven
day
second
inject
day
calv
group
challeng
oral
inocul
approxim
g
duodenali
cyst
day
g
duodenali
challeng
fece
collect
directli
rectum
calf
known
natur
infect
g
duodenali
cyst
calf
isol
enumer
epifluoresc
microscopi
use
method
handley
et
al
polymeras
chain
reaction
pcr
sequenc
carri
inoculum
accord
method
appelbe
et
al
cyst
correspond
g
duodenali
assemblag
e
dose
compris
cyst
mix
ml
phosphatebufferedsalin
dispos
ml
syring
use
oral
inocul
calf
individu
monitor
calv
free
giardia
duodenali
prior
vaccin
fecal
sampl
collect
rectum
calf
daili
examin
g
duodenali
cyst
day
vaccin
day
start
day
start
studi
vaccin
fecal
sampl
collect
everi
day
screen
potenti
g
duodenali
infect
compar
g
duodenali
cyst
excret
level
accur
group
follow
g
duodenali
cyst
challeng
fecal
sampl
collect
daili
calf
start
day
challeng
day
studi
termin
day
fecal
consist
monitor
everi
sampl
score
either
normal
fece
hold
form
abnorm
fece
take
shape
collect
contain
ohandley
et
al
giardia
duodenali
cyst
isol
fece
enumer
epifluoresc
microscopi
accord
method
handley
et
al
calv
euthan
day
intraven
inject
pentobarbit
method
ohandley
et
al
use
enumer
g
duodenali
trophozoit
intestin
calf
addit
sampl
duodenum
proxim
jejunum
distal
jejunum
ileum
cm
length
immedi
place
buffer
formalin
follow
h
fixat
tissu
trim
process
histolog
examin
tissu
stain
haematoxylin
eosin
stain
initi
evalu
addit
slide
examin
use
giemsa
prepar
section
intestin
examin
light
microscop
section
evalu
subject
specif
increas
lymphocyt
plasma
cell
eosinophil
popul
section
judg
either
normal
abnorm
base
cellular
infiltr
degre
enter
grade
minim
mild
moder
sever
section
contain
protozo
structur
note
blood
sampl
collect
calf
venipunctur
week
begin
day
arriv
avc
day
day
challeng
g
duodenali
cyst
day
challeng
venou
blood
sampl
collect
twiceweekli
day
euthanasia
day
g
duodenalisspecif
antibodi
serum
determin
calf
use
g
duodenaliselisa
design
previous
use
bovin
serum
dilut
ohandley
et
al
differ
antibodi
titer
od
valu
vaccin
nonvaccin
calv
assess
use
repeat
measur
anova
titer
measur
vaccin
pbsinject
respect
includ
analysi
approxim
normal
distribut
trophozoit
cyst
count
natur
logtransform
geometr
mean
calcul
trophozoit
count
intestin
segment
analyz
geometr
mean
perform
natur
logtransform
valu
ad
intestin
trophozoit
fecal
cyst
count
mean
number
cyst
shed
vaccin
nonvaccin
calv
compar
use
nonparametr
wilcoxon
test
test
fecal
cyst
count
day
challeng
includ
test
also
appli
compar
trophozoit
count
vaccin
nonvaccin
calv
intestin
segment
analys
perform
use
stata
tm
statacorp
colleg
station
texa
usa
valu
p
consid
statist
signific
start
studi
mean
serum
titer
od
valu
vaccin
nonvaccin
group
respect
fig
serum
antibodi
titer
decreas
first
week
studi
lowest
vaccin
nonvaccin
group
respect
day
vaccin
pbsinject
vaccin
antibodi
titer
increas
vaccin
calv
significantli
higher
nonvaccin
calv
fig
p
antibodi
titer
vaccin
group
increas
time
remain
rel
stabl
nonvaccin
group
p
giardia
duodenali
cyst
observ
calv
oral
challeng
cyst
excret
increas
day
challeng
day
challeng
calv
group
shed
g
duodenali
cyst
mean
number
cyst
shed
fece
tend
higher
vaccin
calv
compar
nonvaccin
calv
fig
p
mean
number
cyst
shed
vaccin
nonvaccin
calv
day
seven
fourteen
challeng
cystsg
fece
confid
interv
cystsg
fece
confid
interv
respect
geometr
mean
g
duodenali
trophozoit
count
per
centimet
higher
section
small
intestin
vaccin
compar
nonvaccin
calv
tabl
wilcoxon
test
howev
signific
differ
count
vaccin
nonvaccin
group
intestin
segment
smallest
p
distal
jejunum
two
calv
demonstr
chang
duodenum
consist
moder
enter
one
calf
vaccin
group
one
calf
vaccin
abnorm
found
upon
examin
histolog
prepar
calv
trophozoit
found
slide
vaccin
group
two
calv
experienc
diarrhea
respiratori
tract
problem
g
duodenali
challeng
two
calv
group
respiratori
tract
problem
diarrhea
g
duodenali
challeng
one
calf
nonvaccin
group
diarrhea
respiratori
tract
problem
challeng
three
calv
group
respiratori
tract
problem
diarrhea
g
duodenali
challeng
g
duodenali
cyst
detect
fece
five
calv
experienc
diarrhea
challeng
g
duodenali
cyst
cryptosporidium
parvum
oocyst
observ
fece
four
calv
one
calf
nonvaccin
group
experienc
diarrhea
challeng
short
bout
diarrhea
fourth
day
challeng
g
duodenali
cyst
c
parvum
oocyst
detect
fece
calf
diagnost
test
pursu
caus
diarrhea
perform
calv
diagnost
servic
avc
perform
postmortem
examin
calf
die
vaccin
clinic
sign
gross
microscop
find
observ
consist
acut
neonat
diarrhea
dehydr
cardiovascular
collaps
etiolog
agent
detect
submit
specimen
c
parvum
coronaviru
differ
fecal
score
two
group
calv
continu
eat
challeng
sever
clinic
sign
observ
infect
g
duodenali
despit
significantli
higher
humor
immun
respons
vaccin
compar
nonvaccin
calv
subcutan
vaccin
giardiasi
calv
efficaci
reduc
cyst
shed
signific
differ
vaccin
nonvaccin
calv
respect
number
trophozoit
present
per
cm
small
intestin
calv
shed
g
duodenali
cyst
challeng
vaccin
calv
tendenc
shed
cyst
nonvaccin
calv
sever
clinic
sign
observ
due
giardiasi
dog
cat
subcutan
administr
g
duodenali
vaccin
result
reduc
number
cyst
shed
fece
lower
number
trophozoit
intestin
increas
feed
intak
well
weight
gain
shorter
time
abnorm
fece
pass
olson
et
al
studi
also
conduct
use
g
duodenali
vaccin
therapeut
agent
dog
cat
olson
et
al
found
dog
suffer
chronic
giardiasi
receiv
treatment
g
duodenali
vaccin
ceas
shed
fecal
cyst
clinic
sign
disappear
howev
numer
studi
fail
demonstr
signific
effect
payn
et
al
stein
et
al
anderson
et
al
reminisc
result
present
paper
anderson
et
al
report
dog
vaccin
group
shed
g
duodenali
compar
nonvaccin
group
although
fewer
vaccin
dog
posit
g
duodenali
end
studi
knowledg
use
vaccin
giardiasi
calv
report
previous
specul
vaccin
fail
prevent
g
duodenali
infect
calv
vaccin
failur
calv
may
due
larg
inocul
dose
use
challeng
due
continu
exposur
cyst
within
environ
follow
challeng
despit
regular
clean
disinfect
howev
higher
challeng
dose
g
duodenali
cyst
use
vaccin
studi
vaccin
efficaci
olson
et
al
antibodi
titer
dog
cat
increas
rapidli
within
week
vaccin
olson
et
al
titer
increas
rapidli
booster
inject
day
studi
calv
given
booster
inject
day
week
initi
vaccin
week
later
cat
dog
nevertheless
serolog
respons
calv
follow
similar
trend
dog
cat
titer
increas
within
week
vaccin
increas
rapidli
booster
inject
possibl
presenc
matern
antibodi
calv
could
interf
vaccin
studi
group
similar
mean
antibodi
titer
presum
matern
antibodi
begin
studi
declin
prior
vaccin
although
previou
studi
demonstr
matern
antibodi
g
duodenali
declin
within
day
dairi
calv
suffici
matern
antibodi
may
present
vaccin
carri
group
calv
howev
impact
matern
antibodi
vaccin
efficaci
controversi
recent
studi
indic
good
vaccin
efficaci
despit
administr
presenc
matern
antibodi
martelli
et
al
zimmerman
et
al
studi
report
neg
impact
matern
antibodi
vaccin
efficaci
studi
examin
immun
respons
rumin
follow
g
duodenali
infect
weak
serum
immun
respons
observ
follow
natur
infect
lamb
calv
thought
account
part
chronic
infect
rumin
yank
et
al
ohandley
et
al
although
calv
mount
serolog
immun
respons
follow
vaccin
possibl
vaccin
stimul
immun
local
within
gut
local
immun
respons
import
elimin
infect
gottstein
et
al
addit
recent
research
shown
rumin
commonli
infect
g
duodenali
correspond
genet
assemblag
e
ohandley
et
al
appelbe
et
al
trout
et
al
trout
et
al
trout
et
al
also
genotyp
use
challeng
calv
studi
although
genotyp
g
duodenali
compris
vaccin
known
would
assemblag
e
assemblag
yet
cultur
vitro
thu
antigen
differ
genet
assemblag
could
account
failur
vaccin
prevent
g
duodenali
infect
calv
